CAMBRIDGE, MA -- Avaki Corporation, a pioneer in global grid software solutions, announced today it has co-authored a proposed standard for identifying biologically significant data in life sciences applications. The proposal, submitted to the Technical Architecture working group of the Interoperable Informatics Infrastructure Consortium (I3C), is co-authored by members from Whitehead/MIT Center for Genome Research, AVAKI, and Millennium Pharmaceuticals.